Khoja Hamid
Chief Scientific Officer
PurchaseAlert
- Shares
- 30,000
- Price
- $0.38
- Value
- $11,400
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•16 filings
FBLG
FibroBiologics, Inc.
No net buying or selling imbalance over the last 3 months
No net buyers or sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found 4 CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
$0.00
0 buyers · 0 sellers
12-month purchases
$120,560
4 distinct insiders
12-month sales
$0.00
0 distinct insiders
Highlighted alerts
7
0 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
4 executive purchases found
Get FBLG insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
FBLG overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
17
Raw transactions
Everything returned by the filing
7
Voluntary view
P/S trades after deterministic checks
10
Administrative noise
Stored, never alerted
0
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- A
- Shares
- 298,508
- Price
- $1.68
- Footnotes
- 3
On September 15, 2026, the reporting person entered into a securities purchase agreement with FibroBiologics, Inc. (the "Company") to purchase 298,508 shares of the Company's common stock, par value $0.00001 per share (the "Common Stock"), and accompanying warrants to purchase up to 298,508 shares of Common Stock (the "Warrants"), in a private placement (the "Offering"). Each share of Common Stock and accompanying Warrant were issued at a combined purchase price of $1.675. The warrants are exercisable at any time until they expire.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
O'HEERON PETE
CHIEF EXECUTIVE OFFICER
PurchaseAlert
- Shares
- 15,872
- Price
- $0.38
- Value
- $6,006
O'HEERON PETE
CHIEF EXECUTIVE OFFICER
PurchaseAlert
- Shares
- 18,200
- Price
- $0.41
- Value
- $7,373
O'HEERON PETE
CHIEF EXECUTIVE OFFICER
PurchaseAlert
- Shares
- 17,428
- Price
- $0.35
- Value
- $6,152
Davis Jason
Chief Financial Officer
PurchaseAlert
- Shares
- 70,000
- Price
- $0.41
- Value
- $28,973
GARCIA RUBEN A
General Counsel
PurchaseAlert
- Shares
- 40,000
- Price
- $0.33
- Value
- $13,056
GARCIA RUBEN A
General Counsel
PurchaseAlert
- Shares
- 140,000
- Price
- $0.34
- Value
- $47,600
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Mar 04, 2026 | Khoja Hamid Chief Scientific Officer | Purchase | 30,000 | $0.38 | $11,400 | |
| Mar 04, 2026 | O'HEERON PETE CHIEF EXECUTIVE OFFICER | Purchase | 15,872 | $0.38 | $6,006 | |
| Mar 03, 2026 | O'HEERON PETE CHIEF EXECUTIVE OFFICER | Purchase | 18,200 | $0.41 | $7,373 | |
| Mar 02, 2026 | O'HEERON PETE CHIEF EXECUTIVE OFFICER | Purchase | 17,428 | $0.35 | $6,152 | |
| Mar 02, 2026 | Davis Jason Chief Financial Officer | Purchase | 70,000 | $0.41 | $28,973 | |
| Feb 27, 2026 | GARCIA RUBEN A General Counsel | Purchase | 40,000 | $0.33 | $13,056 | |
| Dec 11, 2025 | GARCIA RUBEN A General Counsel | Purchase | 140,000 | $0.34 | $47,600 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.